Latest Insider Transactions at Adamis Pharmaceuticals Corp (ADMP)
This section provides a real-time view of insider transactions for Adamis Pharmaceuticals Corp (ADMP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Adamis Pharmaceuticals Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Adamis Pharmaceuticals Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2023
|
Ebrahim Versi CEO |
BUY
Conversion of derivative security
|
Indirect |
729,200
+44.58%
|
-
|
|
May 25
2023
|
Jannine Versi Director |
BUY
Grant, award, or other acquisition
|
Indirect |
177,194
+50.0%
|
-
|
|
May 25
2023
|
Meera J. Desai Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,138
+50.0%
|
-
|
|
May 25
2023
|
Ebrahim Versi CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
177,194
+50.0%
|
-
|
|
May 25
2023
|
Ebrahim Versi CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,745
+50.0%
|
-
|
|
May 25
2022
|
Dennis J Phd Carlo |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+31.81%
|
-
|
|
Mar 18
2022
|
David C. Benedicto Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,603
-8.29%
|
$0
$0.61 P/Share
|
|
Mar 18
2022
|
Dennis J Phd Carlo |
SELL
Open market or private sale
|
Direct |
10,490
-3.54%
|
$0
$0.6 P/Share
|
|
Mar 18
2022
|
David J. Marguglio SVP and Chief Business Officer |
SELL
Open market or private sale
|
Direct |
11,859
-4.83%
|
$0
$0.6 P/Share
|
|
Mar 18
2022
|
Ronald B. Moss Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,199
-3.9%
|
$0
$0.6 P/Share
|
|
Dec 01
2021
|
Dennis J Phd Carlo |
SELL
Open market or private sale
|
Direct |
47,870
-13.91%
|
$0
$0.78 P/Share
|
|
Dec 01
2021
|
David J. Marguglio SVP and Chief Business Officer |
SELL
Open market or private sale
|
Direct |
50,757
-16.4%
|
$0
$0.78 P/Share
|
|
Dec 01
2021
|
Ronald B. Moss Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
35,553
-14.47%
|
$0
$0.78 P/Share
|
|
Dec 01
2021
|
David C. Benedicto Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,554
-23.77%
|
$0
$0.78 P/Share
|
|
Feb 21
2021
|
Dennis J Phd Carlo |
BUY
Exercise of conversion of derivative security
|
Direct |
27,822
+7.48%
|
-
|
|
Feb 21
2021
|
Ronald B. Moss Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,911
+5.36%
|
-
|
|
Feb 21
2021
|
David J. Marguglio SVP and Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,258
+6.71%
|
-
|
|
Feb 21
2021
|
Robert O Hopkins Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,258
+7.44%
|
-
|
|
Nov 20
2020
|
Robert O Hopkins Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
35,000
-12.08%
|
$0
$0.41 P/Share
|
|
Nov 20
2020
|
David J. Marguglio SVP and Chief Business Officer |
SELL
Open market or private sale
|
Direct |
35,000
-10.86%
|
$0
$0.4 P/Share
|
|
Nov 18
2020
|
David J. Marguglio SVP and Chief Business Officer |
SELL
Open market or private sale
|
Direct |
8,532
-2.58%
|
$0
$0.41 P/Share
|
|
Nov 18
2020
|
Karen K. Daniels VP of Operations |
SELL
Open market or private sale
|
Direct |
5,333
-3.45%
|
$0
$0.41 P/Share
|
|
Nov 18
2020
|
Dennis J Phd Carlo |
SELL
Open market or private sale
|
Direct |
10,665
-3.26%
|
$0
$0.41 P/Share
|
|
Nov 18
2020
|
Robert O Hopkins Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,229
-2.43%
|
$0
$0.41 P/Share
|
|
Nov 18
2020
|
Ronald B. Moss Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,532
-3.55%
|
$0
$0.41 P/Share
|
|
Sep 29
2020
|
David J. Marguglio SVP and Chief Business Officer |
SELL
Open market or private sale
|
Direct |
20,000
-6.09%
|
$0
$0.8 P/Share
|
|
Sep 29
2020
|
Robert O Hopkins Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-6.78%
|
$0
$0.8 P/Share
|